MetaCap

Baird Medical Investment (BDMD) vs SkyAI (SKYA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

SkyAI (SKYA) has outperformed Baird Medical Investment (BDMD) over the past year, losing 23.0% versus a loss of 93.6%. SkyAI is the larger company by market cap ($7.8 million vs $5.1 million), about 1.5 times the size. Baird Medical Investment converts more of its revenue into profit, with a net margin of -121.0% versus -138400.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDMD-93.64%SKYA-22.97%
+156%+25%-106%
Nov 21, 20251 yearNov 20, 2026
BDMD-99.10%SKYA-99.98%
+21%-42%-106%
Apr 11, 20225 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDMD versus SKYA key metrics
MetricBDMDSKYA
Share price$0.0897$2.18
Market cap$5.07M$7.82M
1-day change-12.91%-45.50%
YTD return-93.40%+7.39%
1-year return-93.64%-22.97%
P/E ratio (TTM)—2.83
Forward P/E0.64—
EPS (TTM)$-0.55$0.77
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$22.54M$204.12K
Revenue growth (YoY)-39.15%—
Net income (latest FY)$-27.28M$-282.50M
Gross margin83.79%-202.49%
Operating margin-113.73%-132145.49%
Net margin-121.04%-138400.02%
52-week high$3.70$4.39
52-week low$0.073$0.91
Distance from 52-week high-97.58%-50.34%
Analyst consensusnone—
Avg. price target upside+4359.31%—
Average volume16.31M1.74M
Shares outstanding56.52M3.59M
Employees14630
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SKYA has outperformed BDMD by 70.7 percentage points over the past year.
  • Baird Medical Investment is more profitable, keeping -121.0 cents of every revenue dollar as net income versus -138400.0 cents for SkyAI.

About Baird Medical Investment

BDMD stock →

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.

Health Care · Medical/Dental Instruments · 146 employees

About SkyAI

SKYA stock →

SkyAI, Inc., a financial technology company with a Solana digital asset treasury that is building an agentic finance platform. It combines stablecoin rails with AI to deliver financial access, education, and actionable intelligence to the underbanked users in Asia, Latin America, and Africa.

Health Care · Medical/Dental Instruments · 30 employees

BDMD vs SKYA FAQ

Which is bigger, Baird Medical Investment or SkyAI?

SkyAI (SKYA) is larger, with a market capitalization of $7.82M compared with $5.07M for Baird Medical Investment (BDMD).

Which stock has performed better over the past year, BDMD or SKYA?

SKYA returned -22.97% over the past 12 months, compared with -93.64% for BDMD (price return, excluding dividends). Past performance does not predict future results.

Are Baird Medical Investment and SkyAI in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons